Key result
Bioprosthetic valves were associated with a higher incidence of prosthetic valve endocarditis than mechanical valves, with antecedent endocarditis further increasing risk.
Why the study?
Does bioprosthetic valve replacement compared to mechanical valve replacement increase the risk of prosthetic valve endocarditis in patients undergoing valve replacement?
Cohort (n=912)
Does bioprosthetic valve replacement compared to mechanical valve replacement increase the risk of prosthetic valve endocarditis in patients undergoing valve replacement?
Bioprosthetic valves, aortic position, and antecedent endocarditis are significant risk factors for the development of prosthetic valve endocarditis.
Answers are grounded in this paper and cite their sources.
Supports closer endocarditis surveillance after bioprosthetic valve replacement; extends observational data but leaves causal inference open.
UNLABELLED: To study the incidence and risk factors of prosthetic valve endocarditis (PVE) we followed 99.5% of 912 patients who had valve replacements from 1 January 1981 to 31 December 1985 for 1-6 (mean 3) years. PVE occurred in 27 patients (2.96% or 0.98% per patient-year). The incidence of PVE in the aortic position (3.9%) was significantly higher than in the mitral position (1.5%): chi-square = 6.1, P less than 0.025. PVE developed in 19 of 329 patients with bioprostheses (5.8%), and in 8 of 583 patients with mechanical valves (1.4%): chi-square = 14.48, P less than 0.005). Actuarially at 5-year follow-up, 90.7% +/- 2.16% of the bioprosthetic group and 98.4% +/- 0.56% of the mechanical valve group was free of PVE (P less than 0.001). Antecedent endocarditis increased both the incidence and relative risk of PVE 7-fold compared to patients without antecedent endocarditis (chi-square = 32.0, P less than 0.0001). Bioprosthetic valve replacement in infective endocarditis increased the risk of PVE 12-fold compared to valve replacement by mechanical prostheses. CONCLUSION: in the order of importance, antecedent endocarditis, bioprostheses and aortic position are risk factors in the development of PVE. Bioprostheses implanted in patients with antecedent endocarditis further enhance the risk of PVE.
No takes yet. Share an insight, caveat, or question.
M Lengyel (1988) conducted a cohort in Prosthetic valve endocarditis (n=912). Bioprosthetic valves vs. Mechanical valves was evaluated on Development of prosthetic valve endocarditis (p=<0.005). Bioprosthetic valves were associated with a higher incidence of prosthetic valve endocarditis than mechanical valves, with antecedent endocarditis further increasing risk.
Synapse has enriched 10 related papers. Consider them for comparative context: